IRCT20231020059773N1 IRCT 2023-12-11 Qazvin University of Medical Sciences Effect of rosuvastatin with dose 40 mg compared to placebo on nerve conduction velocity in64 patients with carpal tunnel syndrome Effect of rosuvastatin with dose 40 mg compared to placebo on nerve conduction velocity in64 patients with carpal tunnel syndrome 2024-01-19 anticipated 64 Complete https://irct.ir/trial/73501 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, the effect of Rosvastatin drug on people with CTS confirmed by electrodiagnostic test with different intensity will be investigated. This study includes 2 population groups, including people who receive a dose of 40 mg of medicine and people who are treated with placebo. The way of selecting people to receive medicine or placebo follows the law of random allocation. In this way, the total sample size in this study is about 64 people with cts People are randomly divided into two groups of 32 people (group a to receive medicine / group b to receive placebo), Blinding description: The method of blinding in this study is designed as single blind. This means that only the participants of this study do not know which group they are in (receiving medicine or placebo). In this study, the researcher/clinical caregiver/outcome assessor/data analyst and the data safety and integrity committee are aware of the allocation of groups. 3 Carpal tunnel syndrome. Intervention 1: Intervention group: Patients receiving Rosuvastatin 40 mg. Intervention 2: Control group: receiving a placebo drug. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is According to the ethical considerations that exist.